Probiotics, IBS and the gut-brain axis: Addressing dysregulation with probiotics and integrative approaches

Article description 

IBS and the Gut-Brain Axis: Addressing dysregulation with probiotics and integrative approaches 

With approximately 33% of individuals having a greater risk of developing mood disorders, the relationship between IBS, the gut microbiota and mental disturbances appears to be an important aspect of IBS pathophysiology. This article explores the impacts of a dysregulated gut-brain axis on IBS and associated mood disorders. 

Author: Mick Alexander - B.Pharm, BHSc (Naturopathy)

Mick Alexander is an integrative pharmacist, naturopath, author, pharmacy educator, and industry presenter who embraces the benefits of combining natural supplements with conventional medicines. He is an Independent Brand Ambassador for fx Medicine, BioCeuticals^® education platform. 

Reviewer: Brett Friedman - MSc (Med), ADNM

Brett Friedman is a qualified nutritional medicine practitioner and scientist with a master’s degree in medicine. He is a Senior Practitioner Learning Designer at BioCeuticals® and fx Medicine. He was involved in reviewing this article. 

Learning objectives 

• Describe the gut-brain axis and its role in irritable bowel syndrome (IBS) 
• Explain the impact of gut dysbiosis on IBS and mental health:  
• Evaluate probiotic interventions for the management of IBS  

Competency standards 3.1, 3.2, 3.5, 3.6, 5.3 

To complete your Pharmacy CPD credits, please see the link at the end of the article.